Amphastar Reports Financial Results For The Three Months And Fiscal Year Ended December 31, 2016 Post author:Sam Post published:March 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçe… February 18, 2018 Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target March 21, 2017 Mylan Launches Generic Gleevec Tablets October 1, 2017
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçe… February 18, 2018
Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target March 21, 2017